Clinical Trials Browser

OTHER × Lymphoma, Large B-Cell, Diffuse × pegylated granulocyte colony-stimulating factor × Clear all

NCT04323956 2026-02-02

Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma

Phase 1 Active not recruiting

Lymphoma, Large B-Cell, Diffuse